Front Row Advisors’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-220
Closed -$2.09K 866
2024
Q2
$2.09K Hold
220
﹤0.01% 849
2024
Q1
$1.69K Buy
+220
New +$2K ﹤0.01% 855
2023
Q4
Sell
-220
Closed -$2.89K 834
2023
Q3
$2.89K Hold
220
﹤0.01% 774
2023
Q2
$3K Hold
220
﹤0.01% 778
2023
Q1
$3K Hold
220
﹤0.01% 793
2022
Q4
$4K Hold
220
﹤0.01% 710
2022
Q3
$3K Hold
220
﹤0.01% 777
2022
Q2
$3K Hold
220
﹤0.01% 781
2022
Q1
$5K Hold
220
﹤0.01% 740
2021
Q4
$4K Hold
220
﹤0.01% 807
2021
Q3
$3K Hold
220
﹤0.01% 836
2021
Q2
$3K Hold
220
﹤0.01% 840
2021
Q1
$3K Hold
220
﹤0.01% 836
2020
Q4
$3K Hold
220
﹤0.01% 799
2020
Q3
$3K Hold
220
﹤0.01% 796
2020
Q2
$1K Hold
220
﹤0.01% 961
2020
Q1
$1K Hold
220
﹤0.01% 942
2019
Q4
$2K Hold
220
﹤0.01% 823
2019
Q3
$2K Hold
220
﹤0.01% 829
2019
Q2
$3K Hold
220
﹤0.01% 783
2019
Q1
$2K Hold
220
﹤0.01% 886
2018
Q4
$2K Hold
220
﹤0.01% 852
2018
Q3
$3 Hold
220
﹤0.01% 743
2018
Q2
$3 Hold
220
﹤0.01% 796
2018
Q1
$3K Hold
220
﹤0.01% 741
2017
Q4
$3K Buy
+220
New +$3.06K ﹤0.01% 640

Other funds holding MDRX

Front Row Advisors's MDRX Position: Q3 2024 in Review

Front Row Advisors sold out of Veradigm Inc. Common Stock (MDRX) in Q3 2024, closing a stake of 220 shares — an estimated $2.09K sold.

Front Row Advisors first reported a position in MDRX in Q4 2017 and held it in 26 quarters. The position peaked at $5K in Q1 2022. 8 funds tracked by Wall St. Rank hold MDRX as of Q3 2024.

  • Front Row Advisors reported no remaining Veradigm Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Front Row Advisors sold 220 Veradigm Inc. Common Stock shares in Q3 2024, an estimated $2.09K.
  • Front Row Advisors first reported a position in Veradigm Inc. Common Stock in Q4 2017 and held it in 26 quarters.
  • Front Row Advisors's Veradigm Inc. Common Stock position peaked at $5K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q3 2024.

Based on Front Row Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.